ACAD compared with KOD: revenue, margins and what each company keeps, and the suppliers and customers both name

ACADAcadia Pharmaceuticals Inc

Mkt capRevenueRevenue

KODKodiak Sciences Inc.

Mkt capRevenueRevenue

Compare

ACADAcadia Pharmaceuticals Inc

KODKodiak Sciences Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

ACAD, solidKOD, dashed

Supply-chain overlap

Revenue flow

KOD: latest quarter not drawable.Method ›

ACADAcadia Pharmaceuticals Inc

20.59▼−0.81%· post 20.59

Mkt cap$3.5BRevenue$308MQ2 FY26Revenue$1.1BFY25

KODKodiak Sciences Inc.

100.68▲+0.28%· post 99.34

ClosedOct 30 '26

Mkt cap$6.2BRevenue—Revenue—

Compare

ClosedOct 30 '26

ACADAcadia Pharmaceuticals Inc

KODKodiak Sciences Inc.

20.59▼−0.81%post 20.59

Price

100.68▲+0.28%post 99.34

$3.5B

Mkt cap

$6.2B

Q2 FY26$308M

Revenue

—

FY25$1.1B

Revenue

—

ACAD20.59▼−0.81%vsKOD100.68▲+0.28%ClosedOct 30 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ACAD 4

STOKStoke Therapeuticssupplier

—Neurenunlistedsupplier

—Single wholesale distributorunlistedcustomer

—Third party distributorsunlistedcustomer

Shared 0

No shared counterparties.

Only KOD 1

—Lonzaunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR